About APHB

AmpliPhi Biosciences Corporation (APHB) is a biotechnology company focused on the development and commercialization of novel bacteriophage-based antibacterial therapeutics designed to target infections that are often resistant to existing antibiotic treatments. To advance its pipeline of bacteriophage-based therapies, AmpliPhi is collaborating with a number of leading organizations, including Intrexon Corporation (XON), the U.S. Army, The Royal Brompton Hospital in London, UK and UK-based University of Leicester.
Primary Exchange: AMEX
SIC Biological Products, (No Diagnostic Substances)
NAICS Biological Product (except Diagnostic) Manufacturing

APHB is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
VXF Vanguard Extended Market ETF 6.8 B 6.8E+09 3,242 3242 0.0% 0 5 K 5284
ITOT iShares Core S&P Total U.S. Stock Market ETF 18.6 B 1.85536E+10 3,550 3550 0.0% 0 25 25

Wait, Before You Leave...